Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma
暂无分享,去创建一个
Y. Lotan | V. Margulis | A. Sagalowsky | S. Shariat | J. Raman | Bi-Wen Yeh | J. Hsieh | Sheau-Fang Yang | Wen-Jeng Wu | Chun‐Nung Huang | N. Singla | Chia-Yang Li | Ching-Chia Li | Wei‐Ming Li | H. Tu | Hsiang-Ying Lee | H. Yeh | Sheng-Chen Wen | S. Woldu | Haley Robyak | H. Ke
[1] D. Santini,et al. The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases , 2018, Supportive Care in Cancer.
[2] Y. Lotan,et al. Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United States. , 2018, Urologic oncology.
[3] Y. Okuno,et al. Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis , 2017, BMC Urology.
[4] Y. Lotan,et al. A Multi‐Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States , 2017, The Journal of urology.
[5] R. Zietse,et al. Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines. , 2017, Journal of the American Society of Nephrology : JASN.
[6] J. Castillo,et al. The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients , 2016, BMC Cancer.
[7] E. Bae,et al. Prognostic impact of hyponatraemia in patients with colorectal cancer , 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[8] S. Popat,et al. Resolution of severe hyponatraemia is associated with improved survival in patients with cancer , 2015, BMC Cancer.
[9] R. Berardi,et al. Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma , 2015, Supportive Care in Cancer.
[10] N. Nonomura,et al. Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy , 2015, International Journal of Clinical Oncology.
[11] T. Choueiri,et al. The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium. , 2014, European urology.
[12] M. Rosner,et al. Electrolyte disorders associated with cancer. , 2014, Advances in chronic kidney disease.
[13] A. Maji,et al. The Incidence of Hyponatraemia and Its Effect on the ECOG Performance Status among Lung Cancer Patients. , 2013, Journal of clinical and diagnostic research : JCDR.
[14] K. Fujita,et al. Preoperative serum sodium is associated with cancer‐specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy , 2013, International journal of urology : official journal of the Japanese Urological Association.
[15] N. Nonomura,et al. Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy , 2012, International journal of urology : official journal of the Japanese Urological Association.
[16] S. Shariat,et al. Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study , 2012, BJU international.
[17] X. Lei,et al. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] J. Coleman,et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle‐invasive and non‐organ confined disease in patients with upper tract urothelial carcinoma , 2012, BJU international.
[19] O. Hansen,et al. The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period. , 2010, Lung cancer.
[20] N. Marcussen,et al. Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma , 2010, British Journal of Cancer.
[21] L. Price,et al. Impact of hospital-associated hyponatremia on selected outcomes. , 2010, Archives of internal medicine.
[22] S. Waikar,et al. Mortality after hospitalization with mild, moderate, and severe hyponatremia. , 2009, The American journal of medicine.
[23] K. Bensalah,et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patients , 2009, BJU international.
[24] W. Lui,et al. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[25] A. Shorr,et al. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients* , 2008, Current medical research and opinion.
[26] N. Vasudev,et al. Prognostic Factors in Renal Cell Carcinoma: Association of Preoperative Sodium Concentration with Survival , 2008, Clinical Cancer Research.
[27] Joon-Oh Park,et al. Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases , 2008, Oncology.
[28] L. Gandhi,et al. Paraneoplastic syndromes associated with small cell lung cancer. , 2006, Journal of the National Comprehensive Cancer Network : JNCCN.
[29] M. Paesmans,et al. A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis , 2000, Supportive Care in Cancer.
[30] W. Gregory,et al. Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma. , 1993, British Journal of Cancer.